Health Equity and Decentralized Trials

Jennifer Dahne; Larry W Hawk Jr

doi:10.1001/jama.2023.6982

Health Equity and Decentralized Trials

JAMA. 2023 Jun 20;329(23):2013-2014. doi: 10.1001/jama.2023.6982.

Authors

Jennifer Dahne^{1

2}, Larry W Hawk Jr³

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston.
² Hollings Cancer Center, Medical University of South Carolina, Charleston.
³ Department of Psychology, University at Buffalo, Buffalo, New York.

PMID: 37261810
DOI: 10.1001/jama.2023.6982

No abstract available

Plain language summary

This Viewpoint discusses the proliferation of decentralized clinical trials during the COVID-19 pandemic and the need for rigorous studies to inform whether decentralized approaches promote or prevent access to clinical trials for people facing health disparities.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Clinical Trials as Topic* / methods
Clinical Trials as Topic* / organization & administration
Health Equity*
Healthcare Disparities
Humans
Pandemics